v3.25.2
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
$ in Thousands
 3 Months Ended
Jun. 28, 2025
USD ($)
segment
Jun. 29, 2024
USD ($)
Mar. 29, 2025
USD ($)
Segment Reporting Information [Line Items]      
Number of reportable segments | segment 3    
Total net revenues $ 321,394 $ 336,172  
Operating income 53,872 39,756  
Cost of goods sold 129,150 161,248  
Selling, general and administrative 110,719 108,248  
Research and development 16,261 14,449  
Amortization of acquired intangible assets 11,392 12,471  
Interest and other (expense) income, net (8,703) 6,957  
Income before provision for income taxes 45,169 46,713  
Net revenues 321,394 336,172  
Depreciation and amortization 28,758 29,136  
Total long-lived assets 286,865   $ 284,052
United States      
Segment Reporting Information [Line Items]      
Total net revenues 242,404 248,902  
Total long-lived assets 213,834   217,212
Japan      
Segment Reporting Information [Line Items]      
Total net revenues 13,648 13,705  
Total long-lived assets 1,228   1,250
Europe      
Segment Reporting Information [Line Items]      
Total net revenues 40,882 47,225  
Total long-lived assets 24,177   20,024
Rest of Asia      
Segment Reporting Information [Line Items]      
Total net revenues 21,648 19,783  
Total long-lived assets 29,828   28,705
Other      
Segment Reporting Information [Line Items]      
Total net revenues 2,812 6,557  
Total long-lived assets 17,798   16,861
Plasma      
Segment Reporting Information [Line Items]      
Total net revenues 129,897 135,910  
Depreciation and amortization 12,153 11,916  
Total long-lived assets 193,740   189,833
Plasma | Plasma      
Segment Reporting Information [Line Items]      
Net revenues 129,897 135,910  
Blood Center      
Segment Reporting Information [Line Items]      
Total net revenues 51,839 66,245  
Depreciation and amortization 1,759 3,453  
Total long-lived assets 38,412   40,337
Blood Center | Blood Center net revenues      
Segment Reporting Information [Line Items]      
Net revenues 51,839 66,245  
Hospital      
Segment Reporting Information [Line Items]      
Total net revenues 139,658 134,017  
Depreciation and amortization 14,846 13,767  
Total long-lived assets 54,713   $ 53,882
Hospital | Hospital net revenues      
Segment Reporting Information [Line Items]      
Net revenues 139,658 134,017  
Apheresis | Blood Center net revenues      
Segment Reporting Information [Line Items]      
Net revenues 51,822 49,094  
Whole Blood | Blood Center net revenues      
Segment Reporting Information [Line Items]      
Net revenues 17 17,151  
Interventional Technologies | Hospital net revenues      
Segment Reporting Information [Line Items]      
Net revenues 58,483 63,044  
Blood Management Technologies | Hospital net revenues      
Segment Reporting Information [Line Items]      
Net revenues 81,175 70,973  
Operating Segments | Plasma      
Segment Reporting Information [Line Items]      
Operating income 48,285 41,723  
Cost of goods sold 49,917 65,338  
Selling, general and administrative 26,198 25,130  
Research and development 5,497 3,719  
Operating Segments | Blood Center      
Segment Reporting Information [Line Items]      
Operating income 10,890 12,779  
Cost of goods sold 25,948 36,180  
Selling, general and administrative 13,682 15,602  
Research and development 1,319 1,684  
Operating Segments | Hospital      
Segment Reporting Information [Line Items]      
Operating income 18,377 16,519  
Cost of goods sold 50,216 48,685  
Selling, general and administrative 62,323 61,190  
Research and development 8,742 7,623  
Corporate      
Segment Reporting Information [Line Items]      
Operating income 53,872 39,756  
Amortization of acquired intangible assets 13,828 17,710  
Acquisition, integration and divestiture related costs (2,682) (12,323)  
Restructuring and restructuring related costs 1,324 7,140  
Digital transformation costs 5,355 6,345  
Remeasurement of contingent consideration 93 0  
Other $ (584) $ 12,253